On December 19, 2025, the National Security Commission on Emerging Biotechnology (NSCEB) announced the publication of a paper entitled “The Future of U.S.-China Biotechnology Competition.” The paper ...

Adding another potential wrinkle to the industry’s work with China is the Biosecure Act, a piece of China-targeting national ...

It took 27 years, but Cytokinetics secured its first U.S. drug approval. On Friday, the Food and Drug Administration cleared ...

If you are a Class 12 science student, chances are you have come across this question more than once. Should you choose ...

The new saw: Development-stage biotechs are maturing. Their drugs are winning approvals and independent commercial launches ...

LIXTE Biotechnology (LIXT) announced it is expanding its collaboration with The University of Texas MD Anderson Cancer Center and pharmaceutical ...

Norgine, a leading European specialty pharmaceutical company, today announced an exclusive licensing agreement under which ...

Cathie Wood’s ARK Investment Management sharply increased its exposure to AI-driven biotechnology and cryptocurrency during ...

TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of Adjusted EBITDA(1) positive operations in Q3 2025 and expects to achieve strong ...

The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on June 19, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of ...

Discover how intellectual property rights protect exclusive pharmaceutical use and brand names in biotechnology, influencing innovation and market dynamics.

A catalyst for technology-based economic development in life sciences . In 1984, three of North Carolina’s largest ...